PHARMOS CORP Net Change in Cash
PHARMOS CORP reported Net Change in Cash of -$1.26 million for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2012-11-19
- PHARMOS CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2012-09-30 was -$237.98K.
- PHARMOS CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2012-06-30 was -$499.14K.
- PHARMOS CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2012-03-31 was -$518.65K.
- PHARMOS CORP cash and cash equivalents, period increase (decrease) for the quarter ending 2011-12-31 was -$264.36K.
- PHARMOS CORP cash and cash equivalents, period increase (decrease) for fiscal 2011 was -$1.60M.
- PHARMOS CORP cash and cash equivalents, period increase (decrease) for fiscal 2010 was -$1.49M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2012-09-30 | -$237.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | -$737.12K derived: sum of 2 quarters · filed 2012-11-19 | -$1.26M 10-Q · filed 2012-11-19 | -$1.52M derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-06-30 | -$499.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | -$1.02M 10-Q · filed 2012-07-30 | -$1.28M derived: sum of 3 quarters · filed 2012-07-30 | -$1.60M derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-03-31 | -$518.65K 10-Q · filed 2012-04-16 | -$783.01K derived: sum of 2 quarters · filed 2012-04-16 | -$1.10M derived: sum of 3 quarters · filed 2012-11-19 | -$1.76M derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-12-31 | -$264.36K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | -$580.21K derived: sum of 2 quarters · filed 2012-11-19 | -$1.24M derived: sum of 3 quarters · filed 2012-11-19 | -$1.60M 10-K/A · filed 2012-02-21 |
| 2011-09-30 | -$315.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | -$978.03K derived: sum of 2 quarters · filed 2012-11-19 | -$1.34M 10-Q · filed 2012-11-19 | -$1.42M derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-06-30 | -$662.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | -$1.02M 10-Q · filed 2012-07-30 | -$1.10M derived: sum of 3 quarters · filed 2012-07-30 | -$1.44M derived: sum of 4 quarters · filed 2012-07-30 |
| 2011-03-31 | -$361.83K 10-Q · filed 2012-04-16 | -$442.39K derived: sum of 2 quarters · filed 2012-04-16 | -$777.08K derived: sum of 3 quarters · filed 2012-04-16 | |
| 2010-12-31 | -$80.56K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | -$415.25K derived: sum of 2 quarters · filed 2012-02-21 | -$1.49M 10-K/A · filed 2012-02-21 | |
| 2010-09-30 | -$334.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$1.41M 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$1.07M 10-Q · filed 2011-08-08 |